Shoals Technologies Group enters the post-earnings week with analysts upgrading price targets and the stock up 6% on the week — yet short sellers are quietly rebuilding, a tension worth watching closely.
The Q1 earnings print on May 5 appears to have pleased the Street. JP Morgan's Mark Strouse raised his target from $9 to $10 just today, reiterating Overweight. Citigroup also lifted its target — from $8.50 to $9.50 — while staying Neutral. Needham reiterated its Buy and $12 target. The direction of travel among bulls is clearly upward: targets had been cut across the board in late February after a difficult Q4 margin print, with JP Morgan, Barclays, Jefferies, RBC, Morgan Stanley, and Citigroup all trimming. The earnings result has partially reversed that sentiment, and the mean analyst target has recovered to roughly $9.94 — about 22% above the current price of $8.13.
The bull and bear debate on Shoals has a clear shape. Bulls point to the company's utility-scale solar exposure, a strengthening backlog, rising international quoting activity, and the longer-term case for EBITDA margin expansion as facility consolidation takes hold. Bears focus on margin pressure, competitive encroachment in balance-of-line solutions, and lingering uncertainty around tariffs and supply chains. Morgan Stanley's Equal-Weight is the outlier in a mainly constructive cohort; the broader consensus remains tilted toward Buy, but the Neutral camp has not capitulated.
Short positioning tells a more complicated story after that positive reaction. Short interest has climbed from around 8.4% of the free float in late March to 9.4% now — a grind higher of roughly one full percentage point over six weeks. The most recent week shows a 3% increase in shares short, even as the stock rallied. That means shorts are not covering into the bounce; they are adding into it. The mid-April peak was around 10.1%, so the current level is off that high but still elevated. Borrow conditions are loose — cost to borrow is just 0.42% per annum, down 9% on the week, and availability is ample — meaning the lending market places no squeeze pressure on this position. The ORTEX short score of 49.7 is firmly mid-range, consistent with an active but not extreme short book.
Options traders are broadly constructive. The put/call ratio of 0.29 is almost exactly in line with its 20-day average of 0.28, and well below the 52-week peak of 0.50. There is no rush to buy downside protection post-earnings — options positioning reflects a calm rather than a hedged market.
On the institutional side, T. Rowe Price is the dominant holder with nearly 14% of shares, having added substantially last quarter. BlackRock and Vanguard also added modestly through March. The notable negative is Encompass Capital, which cut its position by over 7 million shares as of December's filing, making it one of the larger active exits in recent months. With 225 institutional holders and an ownership base that recently skewed toward adding, the register looks supportive.
The key dynamic heading into the next quarter is whether the margin recovery story develops as management has guided, or whether competitive and tariff pressures reassert. The next earnings event is pencilled in for late July — what analysts and shorts do with the stock between now and then will be shaped almost entirely by whether the backlog converts cleanly and whether EBITDA margins tighten on schedule.
See the live data behind this article on ORTEX.
Open SHLS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
